Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, which medicines with an EMA Orphan Medicines Product designation have been appraised by NICE through a Single Technology Appraisal process; and what category of recommendation, (a) recommended, (b) optimised, (c) Cancer Drugs Fund, (d) not recommended and (e) only in research, was made in each case.
The attached table lists medicines with a European Medicines Agency orphan designation appraised by the National Institute for Health and Care Excellence through the single technology appraisal process and the category of recommendation made in each case.